Empa-Kidney

Empa-Kidney

Professional Development

5 Qs

quiz-placeholder

Similar activities

Stroke 19-33

Stroke 19-33

University - Professional Development

5 Qs

RC DIABETES TRULICITY/BASAGLAR

RC DIABETES TRULICITY/BASAGLAR

Professional Development

8 Qs

Antidiabeticos orales

Antidiabeticos orales

Professional Development

10 Qs

Respiration

Respiration

Professional Development

10 Qs

Plant Nutrients Review

Plant Nutrients Review

10th Grade - Professional Development

10 Qs

10 câu hỏi về Glucose & sức khỏe

10 câu hỏi về Glucose & sức khỏe

Professional Development

10 Qs

The Digestive system

The Digestive system

6th Grade - Professional Development

10 Qs

Plant nutrition

Plant nutrition

11th Grade - Professional Development

9 Qs

Empa-Kidney

Empa-Kidney

Assessment

Quiz

Biology

Professional Development

Easy

Created by

Sardar Muhammad Shoaib Khan

Used 2+ times

FREE Resource

5 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the prevalence of diabetes in Pakistani adults?

25%

15%

35%

5%

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Which of the following is not an SGLT2 inhinbitor?

Gluroflozin

Empagliflozin

Ertugliflozin

Canagliflozin

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

SGLT2 stands for?

Sodium glucose Transporter 2

Sodium Glucose Lactose Tolerance 2

Sugar Glucose Transporter 2

Sodium Glucose Type 2

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Empa - Kidney was a

Randomised controlled trial

Case study

Observational study

Open-label study

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

In light of Empa kidney trial, giving empagliflozin to a patient with CKD stage 2 would,

Increase his risk of end stage renal disease

Increase his risk of a heart attack

Decrease his risk of stroke

Increase his risk of developing diabetes